SVP of Strategy
Cognosante Appoints Bridget Gauer as SVP of Strategy
Cognosante announced that it has appointed public health sector veteran Bridget Gauer as the company's senior vice president of strategy.
Gauer brings into the role over 25 years of acquisition and leadership expertise from working in several federal agencies, Cognosante said Monday.
"She will be an excellent addition to our leadership team as she supports the company’s overall growth process from pursuit to execution,” said Michele Kang, founder and CEO of Cognosante.
Kang added that Gauer's addition to Cognosante's executive team will help the company reach its next level of size and scope.
Gauer most recently served as the director of the National Institutes of Health Information Technology Acquisition and Assessment Center.
In the said role, she was responsible for setting the strategic vision for the agency's government-wide acquisition contract program.
Her portfolio included the Chief Information Officer–Solutions and Partners 3, CIO-SP3 Small Business and CIO-Commodities and Solutions contract vehicles.
Gauer also served as the division director of contracts for the Department of Health and Human Services' assistant secretary of preparedness and response.
She was the acting director for HHS' acquisition program support division within the Office of Acquisition Management, Contracts and Grants Office.
Gauer also held leadership positions in the Federal Communications Commission and the Department of Homeland Security.
“I am incredibly excited to join Cognosante. This role provides an opportunity for me to apply my government and leadership experience in a new capacity while focusing on strategy and growth," Gauer said.
She earned a bachelor's degree in recreation, a master's degree in business administration and a master's degree in national security and strategic studies from the Naval War College.
Category: Partnerships and Executive Moves
Tags: Bridget Gauer Cognosante Health and Human Services Michele Kang National Institutes of Health NIH Partnerships and Executive Moves